US Activist Hedge Fund Institutional SEC 13D 13G — June 24, 2026

24-06-2026

Lawrence M. Blatt, Ph.D. (Chairman, President, and CEO of Aligos Therapeutics) filed a Schedule 13D on June 24, 2026, disclosing beneficial ownership of 316,228 shares of Common Stock (5.6% of outstanding voting shares) as of June 16, 2026. The filing indicates Blatt may consider various strategic alternatives including mergers, take-private transactions, or other corporate changes, but currently has no definitive plans. The filing reflects a significant insider position and potential catalyst for corporate action, though no immediate changes are planned.

• · The Reporting Person did not effect any transactions in the Common Stock during the past 60 days.
• · The 316,228 shares beneficially owned consist of shares held directly and through trusts, an IRA, exercisable warrants, and stock options exercisable within 60 days.
• · Blatt stated he may consider extraordinary corporate transactions such as a merger, reorganization, take-private, security offerings, stock repurchases, asset sales, or changes to capitalization/dividend policy, but currently has no specific plans.
• · The filing includes warrants for 12,206 shares acquired in a private placement on October 25, 2023.

24-06-2026

S.H.N. Financial Investments Ltd. filed a Schedule 13G with the SEC on June 24, 2026, disclosing beneficial ownership of 851,700 shares of Tianci International, Inc. common stock, representing 9.99% of the 7,673,907 shares outstanding. The reported securities include 750,000 common shares and 101,700 pre-funded warrants, and are subject to a 9.99% beneficial ownership limitation, with additional warrants and pre-funded warrants held outside this limitation.

• · The 13G filing is under Rule 13d-1(c), indicating the holder is a passive investor not seeking control.
• · S.H.N. Financial Investments Ltd. is based in Herzliya, Israel.
• · Nir Shamir, as CEO, may be deemed to beneficially own the securities but disclaims beneficial ownership for all other purposes.
• · The beneficial ownership limitation is set at 9.99%, preventing the holder from exceeding this threshold even if warrants were exercised.
• · Unreported securities include 298,300 pre-funded warrants and 1,150,000 warrants, also subject to the same limitation.

24-06-2026

MCB PR Capital LLC, MCB Acquisitions Manager LLC, and P. David Bramble filed Amendment No. 5 to their Schedule 13D for Whitestone REIT (WSR), disclosing the disposition of common shares that reduced their beneficial ownership below 5% as of June 22, 2026. This final amendment serves as an exit filing, terminating their obligation to report changes in ownership under Section 13(d). The filing also notes a prior SEC settlement in May 2026 resulting in a $75,000 civil penalty for a late filing violation.

• · The Reporting Persons sold 4,175,005 common shares on June 22, 2026 at $18.9188 per share.
• · An additional 193 shares were sold on May 12, 2026 at $18.98 per share.
• · On May 4, 2026, MCB Acquisitions Manager LLC entered into an SEC settlement for failing to timely file its Schedule 13D, paying a $75,000 civil penalty without admitting or denying findings.
• · The Reporting Persons' business address is 2002 Clipper Park Road, Suite 105, Baltimore, MD 21211.

24-06-2026

Blackstone Inc. and affiliated entities filed Amendment No. 9 to Schedule 13D, disclosing that on June 23, 2026, Blackstone Private Multi-Asset Credit and Income Fund (BMACX) acquired 765,110.941 common shares for $20,000,000, increasing the aggregate beneficial ownership of the reporting group to 26,510,439.19 shares, or 69.7% of the 38,012,377.462 outstanding common shares of Blackstone Private Real Estate Credit & Income Fund. The filing also details the complex ownership chain, with BCRED X Holdings LLC directly holding 18,628,294.597 shares (49.0%) and BMACX directly holding 7,882,144.593 shares (20.7%). No transactions were reported in the past 60 days aside from the BMACX subscription.

• · The filing is Amendment No. 9 to Schedule 13D, originally filed on June 27, 2025, with eight prior amendments.
• · The source of funds for BMACX's $20,000,000 purchase was working capital.
• · The ownership chain for BCRED X includes Blackstone Private Credit Fund as sole member, with Blackstone Private Credit Strategies LLC as investment adviser and Blackstone Credit BDC Advisors LLC as sub-adviser.
• · Stephen A. Schwarzman is the ultimate controlling person through Blackstone Group Management L.L.C., which is wholly-owned by Blackstone's senior managing directors and controlled by Schwarzman.
• · No transactions in common shares were effected by any reporting person in the past 60 days other than the BMACX subscription described.

24-06-2026

James H. Dahl and Rainey E. Lancaster filed an amendment to their Schedule 13D for AMREP Corp., disclosing combined beneficial ownership of 998,729 shares (18.8% of total outstanding) as of June 24, 2026. During the period April 25–June 24, 2026, James H. Dahl made a series of open-market purchases totaling 22,731 shares at weighted average prices ranging from $24.50 to $27.85 per share, representing a significant increase in his holdings. The filing also confirms no change in the aggregate ownership percentages from the previous amendment.

• · James H. Dahl purchased 5,000 shares on April 29, 2026 at $27.74; 3,000 shares on May 1 at $27.85; 1,156 shares on May 13 at $24.72; 5,000 shares on May 20 at $24.50; 3,000 shares on May 29 at $25.67; 1,000 shares on May 29 at $27.63; 1,500 shares on June 2 at $26.62; and 3,075 shares on June 22, 2026 at $25.58.
• · Rainey E. Lancaster made no purchases or sales during the 60-day period, maintaining 173,750 shares with shared control.
• · Dahl's sole holdings include 501,708 shares held directly and 204,151 shares in a Roth IRA; he has no pecuniary interest in the 94,120 shares held by the Dahl Family Foundation.

24-06-2026

On June 24, 2026, Millennium Management LLC, together with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G disclosing beneficial ownership of 9,233,757 shares of DXC Technology Company common stock, representing a 5.7% stake as of June 16, 2026. The filing indicates the shares are held for investment purposes and were not acquired with the intent to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Millennium Management LLC and Millennium Group Management LLC each reported sole voting power and sole dispositive power of zero shares, while shared voting power and shared dispositive power of 9,233,757 shares.
• · Israel A. Englander reported the same share amounts with sole beneficial ownership of zero and shared beneficial ownership of 9,233,757.
• · The filing certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer.

24-06-2026

Global Value Investment Corp. (GVIC) and related parties filed a Schedule 13D/A on June 24, 2026, disclosing beneficial ownership of 3,335,429 shares (6.89%) of Loop Industries, Inc. common stock. The filing also reports that on June 16, 2026, Loop Industries appointed Jeffrey R. Geygan, a director and controlling person of GVIC, to its Board of Directors effective June 22, 2026. The aggregate purchase price for the shares was approximately $5,531,129.60, with recent open-market purchases at prices between $1.32 and $1.45 per share.

• · GVIC's principal business is acting as an investment manager; all shares were purchased for investment purposes in the ordinary course of business.
• · The Reporting Persons reserve the right to acquire additional shares or dispose of some or all shares in the open market or privately.
• · No investor rights agreement or nomination agreement exists between Loop Industries, GVIC, or Jeffrey Geygan regarding his board appointment.
• · Shares may be held in margin accounts and pledged as collateral; a portion of the purchase price may have been obtained through margin borrowing.
• · Recent transactions include purchases by GVIC clients on multiple dates in April–June 2026 at weighted-average prices ranging from $1.32 to $1.45 per share, and a grant of 5,170 shares to Jeffrey Geygan on June 22, 2026 (no price).

24-06-2026

John C. Malone filed Amendment No. 2 to Schedule 13D with the SEC on June 24, 2026, reporting the purchase of 1,495,072 Class A common shares of Liberty Latin America Ltd. on June 22 and 23, 2026. The purchases increased his beneficial ownership to 4,956,900 Class A common shares (approximately 12.6% of outstanding Class A shares) and, due to the ten votes per share of his Class B shares, he holds approximately 29.8% of the total voting power of the issuer. The filing also discloses a prior purchase of 61,059 Class A shares on May 22, 2026 at $8.63 per share, highlighting a significant decline in the stock price between the two purchase dates.

• · The June 22 purchase was at an average price of $4.979 per share, and the June 23 purchase was at an average price of $5.9202 per share.
• · The May 22 purchase was at $8.63 per share, indicating a 42.3% decline in the stock price over the following month.
• · Malone's beneficial ownership includes shares held directly, through the LM Revocable Trust, the Malone Trust, and the Children's Trusts.
• · Malone disclaims beneficial ownership of shares held by the LM Revocable Trust (49,729 Class A and 742,148 Class B) and the Children's Trusts (19,249 Class B).
• · The filing notes that no other transactions in the issuer's common shares were effected by Malone or the related trusts during the past 60 days beyond those reported.

24-06-2026

Farallon Capital Management disclosed a 6.1% beneficial ownership stake in Centessa Pharmaceuticals plc (CNTA), holding 9,370,093 ordinary shares (via ADSs) as of June 16, 2026. The investment manager and its managing members filed a Schedule 13D, stating they believe the securities represent an attractive investment opportunity. The net investment cost is approximately $326.0 million. The filing highlights recent open-market purchases by Farallon Funds over the past sixty days at prices ranging from approximately $39.51 to $40.25 per ADS.

• · The Reporting Persons acquired securities through nine separate Farallon investment partnerships (Farallon Funds).
• · All transactions were open-market purchases; no selling transactions were reported in the past sixty days.
• · Trading prices in the past sixty days ranged from $39.51 (May 1, 2026) to $40.25 (June 23, 2026).
• · The largest single-day purchase was 454,791 shares on June 16, 2026 at $39.70.
• · The filing includes a joint acquisition statement (Exhibit 99.1) and detailed sixty-day trading history (Exhibit 99.2).
• · No contracts, arrangements, understandings, or relationships regarding the securities exist beyond those described.

24-06-2026

Flawless Management Inc., Arethusa Properties LTD, and Harry N. Vafias filed Amendment No. 11 to their Schedule 13D, disclosing updated beneficial ownership in Imperial Petroleum Inc. as of June 22, 2026. The filing reports that Harry N. Vafias now beneficially owns 14,266,903 shares (31.9% of common stock), while Flawless Management holds 6,991,255 shares (15.7%) and Arethusa Properties holds 3,307,452 shares (7.4%). The amendment reflects recent open market purchases, a transfer of shares from Mr. Vafias's father, and new compensatory awards to Mr. Vafias.

• · The filing is Amendment No. 11 to the original Schedule 13D filed on August 4, 2023.
• · Arethusa Properties acquired 241,225 shares in open market purchases between December 11-12, 2025 for $1,039,977.71.
• · 33,627 shares were transferred from Nikolaos Vafias to Harry Vafias without consideration on June 22, 2026.
• · Harry Vafias received 440,000 restricted shares (50% vest June 22, 2027; 50% vest June 22, 2028) and options for 299,000 shares at $4.95 (expire June 22, 2036) as compensatory awards on June 22, 2026.
• · Previously awarded options for 50,000 shares at $3.60 and 117,188 shares at $3.20 have vested; options for 149,502 shares at $3.01 are scheduled to vest by August 8, 2026.
• · The Reporting Persons reserve the right to change their intentions regarding the investment, including potential extraordinary corporate transactions.

24-06-2026

RA Capital Management, L.P. and its affiliates filed a Schedule 13D/A disclosing a 11.9% beneficial ownership stake in Solid Biosciences Inc. as of June 22, 2026. The filing details recent open market and at-the-market purchases totaling approximately 2.7 million shares, increasing their position. However, the Fund holds pre-funded warrants for 8,178,412 additional shares that are currently blocked from exercise due to a 9.99% beneficial ownership limitation, indicating a significant but constrained potential upside.

• · The Fund purchased 338,100 shares in open market on June 18, 2026 at prices ranging from $8.25 to $8.35 (weighted-average $8.30).
• · The Fund purchased 2,358,048 shares in an at-the-market offering on June 22, 2026 at $8.20 per share.
• · Pre-funded warrants for 8,178,412 shares are currently blocked from exercise due to a 9.99% beneficial ownership limitation.
• · The filing is Amendment No. 13 to the original Schedule 13D filed on February 9, 2018.
• · RA Capital serves as investment adviser for the Fund, Nexus Fund, and Account, with delegated voting and dispositive power.

24-06-2026

YZi Labs Management Ltd. and Changpeng Zhao filed an amended Schedule 13D disclosing a cooperation agreement with CEA Industries Inc. dated June 23, 2026. Under the agreement, the board will expand to six directors with three YZi Labs appointees (Ling 'Ella' Zhang, Alex Odagiu, Matthew Roszak), a CEO search committee will be formed, and Alex Odagiu will serve as Interim President. YZi Labs beneficially owns 2,150,481 shares (5.07%) but holds additional warrants subject to a 4.99% beneficial ownership limitation that currently prohibits exercise, while Jiajin He beneficially owns 2,099,644 shares (4.95%) including exercisable Stapled Warrants.

• · The Cooperation Agreement terminates upon the earlier of one month before the 2029 nomination deadline or 120 days before the third anniversary of the 2026 Annual Meeting, with potential earlier termination if renomination conditions are not met for the 2027 or 2028 annual meetings.
• · YZi Labs holds 7,750,510 Pre-Funded Warrants (exercise price $0.00001, no expiration), 9,900,991 Stapled Warrants (exercise price $15.15, expire June 28, 2028), and 3,564,359 Strategic Advisor Warrants (exercise price $0.00001, expire August 5, 2030), all subject to a 4.99% beneficial ownership limitation that currently prohibits exercise.
• · Jiajin He holds 1,188,120 shares underlying Stapled Warrants that are currently exercisable without a beneficial ownership limitation.
• · No transactions in shares by the Reporting Persons occurred during the past sixty days.
• · The previous group agreement dated December 19, 2025 was terminated; YZi Labs and Mr. Zhao are no longer part of a Section 13(d) group with the other former members.

24-06-2026

Pacific Ridge Capital Partners, LLC filed an amended Schedule 13G with the SEC on June 24, 2026, reporting that it no longer holds any shares of Sleep Number Corp (SNBR) common stock as of June 5, 2026. The filing indicates a complete exit of the investment manager's position in the company.

• · Pacific Ridge Capital Partners, LLC is a Nevada corporation and an investment adviser (IA).
• · The filing is an amendment to a previous Schedule 13G, indicating a change in ownership.
• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The beneficial owner certifies that the securities were acquired and held in the ordinary course of business, not to change or influence control of the issuer.

24-06-2026

On June 16, 2026, two designees of Arlington Capital Partners (ACP V and ACP VI) — David Wodlinger and Henry Albers — resigned from the board of AeroVironment Inc., effective June 17, 2026, with no disagreement with management. The resignations reduce the board to eight directors, and the shareholder retains the right to designate two successor directors but has not yet done so. The shareholder group collectively holds 12,035,890 shares (24.1% of outstanding common stock), with no transactions in the past 60 days.

• · The resignations were not due to any disagreement with management on operations, policies, or practices.
• · The shareholder retains the right to designate two successor directors to fill the vacancies, but as of the filing date no successors have been designated.
• · No transactions in the issuer's common stock were effected by any reporting person during the past 60 days.
• · The outstanding share count used for percentage calculations is 49,933,993 shares as of March 4, 2026, per the issuer's Form 10-Q/A filed June 22, 2026.

24-06-2026

OrbiMed Advisors LLC and related entities filed Amendment No. 5 to Schedule 13D on June 24, 2026, reporting a decrease in beneficial ownership of Enliven Therapeutics, Inc. (ELVN) common stock by more than 1% following sales on June 22, 2025. The filing discloses that OrbiMed Private Investments VII, LP sold 833,800 shares and OrbiMed Genesis Master Fund, L.P. sold 26,323 shares, while The Biotech Growth Trust PLC reduced its position to zero shares. As of the filing, the OrbiMed group beneficially owns 6,774,507 shares, representing approximately 9.5% of the 71,422,989 outstanding shares, down from a prior level above 10.5%.

• · The filing is an amendment to Schedule 13D originally filed on February 28, 2023, with prior amendments on April 4, 2024, May 20, 2024, June 17, 2025, and June 17, 2026.
• · OrbiMed Advisors exercises voting and investment power through a management committee composed of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares.
• · The Reporting Persons stated they have no current plans for extraordinary corporate transactions, changes in board or management, or other major actions listed in Item 4.
• · The sale prices were $45.38 and $45.00 per share on June 22, 2025.
• · The Reporting Persons have agreed to provide full information regarding the number of shares sold at each separate price upon request by the SEC or the issuer.

24-06-2026

On June 15, 2026, M.N. Business Strategy, led by CEO Moshe Mizrahy, submitted a non-binding proposal to acquire all outstanding shares of InMode Ltd. not already owned by the group for $16.20 per share in cash. The M.N. Business Strategy Affiliates collectively own approximately 7.90% of InMode's ordinary shares (4,539,226 shares) and have obtained a preliminary, non-binding debt financing commitment from Bank Leumi for $200M at SOFR + 3.25% over 4 years. However, the proposal remains non-binding, subject to negotiation of definitive documentation, and the Board has not yet responded, with no guarantee that discussions will lead to a transaction.

• · The proposal is not subject to a financing condition but is non-binding and can be withdrawn or modified at any time.
• · The group includes seven affiliates: Mr. Mizrahy (4,299,226 shares), Bedo Eghiayan (120,000 shares), Michael Avedissian (120,000 shares); other affiliates hold no shares directly.
• · No transactions in the securities were effected by any Reporting Person within the past 60 days.
• · The group intends to fund the acquisition through a combination of internal equity and debt; the Bank Leumi term sheet is preliminary and non-binding.
• · If consummated, the acquisition would likely lead to delisting from Nasdaq and deregistration under the Exchange Act.

24-06-2026

Ephraim G Fields filed a Schedule 13G with the SEC on June 23, 2026, disclosing beneficial ownership of 265,218 shares of HeartSciences Inc. common stock, representing an 8.1% stake in the company. The filing indicates sole voting and dispositive power over all shares, with no shared ownership.

• · Sole voting power: 265,218 shares
• · Sole dispositive power: 265,218 shares
• · No shared voting or dispositive power
• · The filing was made under Section 13(g) of the Securities Exchange Act of 1934
• · HeartSciences Inc. was formerly known as Heart Test Laboratories, Inc. (name change date: July 16, 2009)

24-06-2026

Francisco D. Salva, President, CEO and director of Azitra, Inc., filed a Schedule 13D disclosing beneficial ownership of 5,421,039 shares of common stock, representing 9.99% of the outstanding shares as of June 24, 2026. The ownership includes shares acquired through the automatic conversion of preferred stock on June 16, 2026, incentive stock options, and exercisable warrants. No borrowed funds were used, and Salva holds sole voting and dispositive power over all reported shares.

• · The reporting person acquired preferred stock that automatically converted into 4,064,050 shares of common stock on June 16, 2026.
• · Salva holds warrants to purchase up to 8,128,100 shares of common stock, of which 1,334,748 are exercisable within 60 days; the remainder are subject to a beneficial ownership limitation.
• · All securities were purchased with personal funds; no borrowed funds were used.
• · Salva has sole voting and dispositive power over all 5,421,039 shares held directly.
• · No transactions in common stock were effected by the reporting person during the past 60 days, except as disclosed.

24-06-2026

Tax Credits International Inc (TCI) has disclosed a 46.9% beneficial ownership stake in Made in USA Inc. (ALXYD), owning 9,370,600 shares of common stock. The position was built through two transactions: a purchase of 1,370,600 shares in August 2025 for approximately $2.29 million, and the issuance of 8,000,000 founder/sponsor shares for nominal consideration in October 2025. TCI has sole voting and dispositive power over all shares and may acquire or dispose of additional securities depending on market conditions and the issuer's performance.

• · The filing includes an exhibit list with no exhibits attached (None).
• · TCI acquired founder/sponsor shares for nominal consideration of $200 aggregate.
• · No transactions in the issuer's securities were affected by TCI in the past 60 days.
• · TCI has not been convicted in any criminal proceedings or party to adverse civil securities-related judgments in the past five years.

24-06-2026

Coastlands Capital LP and related entities filed a Schedule 13G on June 24, 2026, disclosing beneficial ownership of 262,167 shares of Adial Pharmaceuticals, Inc. common stock, representing 9.98% of the 2,625,943 shares outstanding as of June 17, 2026. The filing indicates the shares were acquired in the ordinary course of business and not for changing or influencing control of the issuer.

• · The filing excludes pre-funded warrants held by the reporting persons in excess of a beneficial ownership limitation of 4.99%.
• · The shares are held directly by Coastlands Capital Partners LP for the benefit of its investors.
• · The reporting persons disclaim membership in a group and beneficial ownership except for their pecuniary interest.
• · The filing is made pursuant to Rule 13d-1(b) and Rule 13d-1(c) under the Securities Exchange Act of 1934.

24-06-2026

AltraVue Capital, LLC filed an amended Schedule 13G indicating it no longer beneficially owns any shares of Yatra Online, Inc. as of September 8, 2019, representing a 0% ownership stake. The filing reflects the termination of the reporting person's beneficial ownership.

• · AltraVue Capital, LLC ceased to beneficially own any shares as of September 8, 2019.
• · The filing is an amendment to reflect termination of beneficial ownership.

24-06-2026

RBCH Ltd. filed an amended Schedule 13D reporting ownership of 2,222,222 Class B ordinary shares (22.74% of Brera Holdings, post-reverse split) and disclosed that on June 22, 2026, it filed a lawsuit against the issuer in New York Supreme Court. The suit alleges breach of fiduciary duty, oppression, and seeks declaratory and injunctive relief over alleged self-dealing by the board. The beneficial ownership limitation restricts RBCH to no more than 19.99%.

• · A 1-for-10 reverse stock split became effective on May 14, 2026; all share counts in filing are post-split.
• · Viktor Fischer resigned as director on April 5, 2026; his unvested RSUs were forfeited.
• · The lawsuit (RBCH Ltd. v. Sade, et al., Index No. 15780/2026) was filed on June 22, 2026 in New York County Supreme Court.
• · RBCH Ltd. may exercise Common Warrants, subject to a 19.99% beneficial ownership limitation.

24-06-2026

Cevian Capital II GP Ltd filed Amendment No. 7 to its Schedule 13D, reporting beneficial ownership of 110,804,501 ordinary shares of Smith & Nephew plc, representing 13.09% of the outstanding shares. The filing details recent open-market purchases totaling approximately 9,757,713 shares between June 4 and June 24, 2026, at prices ranging from $14.76 to $15.15 per share, reflecting continued accumulation by the activist investor.

• · The filing is Amendment No. 7 to the original Schedule 13D filed on July 9, 2024.
• · All purchases were funded from the Cevian Funds' general working capital and executed using British Pounds.
• · A conversion rate of USD $1.32015 per GBP 1.00 was used for reporting purposes.
• · Cevian Capital II GP Ltd has sole voting power and sole dispositive power over all 110,804,501 Ordinary Shares.
• · The share price during the recent accumulation period ranged from a low of $14.76 (June 23) to a high of $15.15 (June 9).

24-06-2026

Thomas John Corley filed a Schedule 13G/A with the SEC on June 24, 2026, reporting beneficial ownership of 9,001,000 shares of GD Culture Group Ltd common stock, representing 0.9% of the 1,040,619,813 shares outstanding. The filing indicates the shares were acquired and are held for investment purposes, not to influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous Schedule 13G.
• · Thomas John Corley's address is 132 Washington Place, State College, PA 16801.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.
• · GD Culture Group Ltd is incorporated in Nevada and has its business address at 111 Town Square Place, Suite #1203, Jersey City, NJ 07310.
• · The company's former names include Code Chain New Continent Ltd (changed May 18, 2020), TMSR HOLDING Co Ltd (changed February 7, 2018), and JM Global Holding Co (changed May 5, 2015).

24-06-2026

Thrivent Financial for Lutherans filed a Schedule 13G/A disclosing beneficial ownership of 3,200,000 mandatory redeemable preferred shares in Carlyle Tactical Private Credit Fund, representing a 7.27% stake as of June 23, 2026. The filing indicates the shares were acquired in the ordinary course of business without intent to change or influence control of the issuer.

• · Filing is an amendment (SC 13G/A) to a previous Schedule 13G.
• · Thrivent Financial for Lutherans is a Wisconsin fraternal benefit society.
• · The filing was made under Rule 13d-1(d) (passive investor exemption).
• · Sole voting power: 3,200,000 shares; shared voting power: 0; sole dispositive power: 3,200,000 shares; shared dispositive power: 0.

24-06-2026

RP Investment Advisors LP and its affiliated funds filed a Schedule 13G with the SEC on June 24, 2026, disclosing aggregate beneficial ownership of 1,550,924 Class A ordinary shares of HCM III Acquisition Corp., representing 6.1% of the 25,300,000 shares outstanding. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor.
• · The filing certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.
• · A Joint Filing Agreement was executed on June 24, 2026, among all reporting persons.
• · The address of the principal business office for all reporting persons is 39 Hazelton Avenue, Toronto, Ontario, Canada, M5R 2E3.

24-06-2026

Andy Ni filed an amended Schedule 13G with the SEC on June 24, 2026, reporting beneficial ownership of 0 shares of Aditxt, Inc. common stock as of June 22, 2026. The filing indicates that Mr. Ni no longer holds any shares in the company, representing a complete exit from his previous position.

• · Filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · The filing was made pursuant to Rule 13d-1(c), indicating the filer is not an activist investor seeking control.
• · Mr. Ni certifies the securities were not acquired or held to change or influence control of the issuer.
• · The filing date is June 24, 2026, with the event date of beneficial ownership as June 22, 2026.

24-06-2026

On June 24, 2026, RP Investment Advisors LP and affiliated funds filed a Schedule 13G with the SEC, disclosing aggregate beneficial ownership of 1,550,000 Class A ordinary shares of Cantor Equity Partners VII, Inc., representing 6.2% of the 25,000,000 shares outstanding. The filing is a passive investment (Rule 13d-1(c)) with no intent to influence control.

• · Filing is made under Rule 13d-1(c) indicating passive investment intent.
• · All reporting persons are based at 39 Hazelton Avenue, Toronto, Ontario, Canada M5R 2E3.
• · The reporting persons disclaim beneficial ownership for purposes of Section 13(d) or 13(g) of the Act.
• · A Joint Filing Agreement was executed on June 24, 2026, to allow coordinated filings.
• · The issuer is a blank check company (SIC 6770) incorporated in E9 (presumably Cayman Islands) with fiscal year ending December 31.

24-06-2026

Jane Street Group, LLC disclosed a 5.3% beneficial ownership stake in Ascent Solar Technologies, Inc. (ASTI) as of June 17, 2026, holding 501,891 shares of common stock. The filing was made under Rule 13d-1(c) and certifies the securities were not acquired to change or influence control of the issuer.

• · Jane Street Capital, LLC holds 214,499 shares (2.3%) and Jane Street Global Trading, LLC holds 287,392 shares (3.0%) as subsidiaries.
• · The filing is a Schedule 13G (passive investment), not a 13D (activist), indicating no intent to influence control.
• · Filing date is June 24, 2026, with beneficial ownership effective as of June 17, 2026.

24-06-2026

Jane Street Group, LLC filed a Schedule 13G with the SEC on June 24, 2026, disclosing beneficial ownership of 9,727,982 shares of Galaxy Digital Inc. Class A Common Stock, representing a 5.1% stake. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor.
• · Jane Street Group, LLC disclaims beneficial ownership of shares held by its subsidiaries except to the extent of its pecuniary interest.
• · The filing date is June 24, 2026, with the event date of June 17, 2026.
• · Galaxy Digital Inc. is classified under SIC 6211 (Security Brokers, Dealers & Flotation Companies) and is incorporated in Delaware.

24-06-2026

Paradigm BioCapital Advisors LP and related entities filed a Schedule 13G with the SEC, disclosing aggregate beneficial ownership of 2,493,015 shares of MBX Biosciences, Inc. common stock, representing 5.2% of shares outstanding as of June 16, 2026. The filing includes a joint filing agreement among the reporting persons.

• · Filing type: Schedule 13G (passive investment, not 13D).
• · Date of filing: June 24, 2026; date of event requiring filing: June 16, 2026.
• · Paradigm BioCapital International Fund Ltd. holds 2,187,207 shares (4.6%) of MBX.
• · The Adviser, its GP, and Dr. Asefaw disclaim beneficial ownership of shares beyond those directly owned.

24-06-2026

Imperial Petroleum Inc. filed Amendment No. 11 to its Schedule 13D for C3is Inc., reporting beneficial ownership of 7,171,543 common shares, representing 82.9% of the outstanding stock as of June 22, 2026. The filing reflects a conversion price adjustment of the Series A Convertible Preferred Stock to $2.0916 per share and dilution in Imperial Petroleum's percentage ownership due to share issuances under C3is's at-the-market sales program. Harry N. Vafias, Chairman and CEO of Imperial Petroleum, also serves as Non-Executive Chairman of C3is and beneficially owns 718 common shares through entities.

• · Conversion price of Series A Convertible Preferred Stock adjusted to $2.0916 per share due to adjustment of Class D Warrants exercise price during adjustment period ending June 22, 2026.
• · Harry N. Vafias beneficially owns 718 common shares through Arethusa Properties LTD and Flawless Management, Inc.
• · John Kostoyannis and George Xiradakis each own nil shares of C3is Common Stock as of the filing date.
• · Imperial Petroleum reserves the right to acquire additional shares or sell all/portion of holdings in open market, block trades, underwritten offerings, or private transactions.
• · No transactions in Common Stock by Imperial Petroleum or Covered Persons during the past 60 days.
• · The filing is Amendment No. 11, originally filed July 28, 2023, with multiple prior amendments.

24-06-2026

Etika Automotive Sdn Bhd filed a Schedule 13D disclosing beneficial ownership of 179,754,096 ordinary shares of Lotus Technology Inc., representing 27.8% of the 647,687,049 outstanding shares as of May 20, 2026. The filing also reveals that on June 10, 2026, Etika received 23,517,767 ordinary shares from Lotus Group International Limited in settlement of a put option exercised on June 30, 2025, while Geely International (Hong Kong) Limited received 24,477,676 shares in a related transaction. Following these distributions, LGIL ceased to beneficially own more than 5% of the issuer's outstanding shares.

• · Etika Automotive Sdn Bhd is an investment holding company with automotive-related business, incorporated in Malaysia.
• · The put option agreements were originally entered into on January 31, 2023, with Geely HK and Etika each granted the right to require the issuer to purchase all equity interests in Lotus Advance Technologies Sdn. Bhd.
• · Geely HK exercised its put option on April 14, 2025, requiring purchase of 51% of Lotus Advance Technologies; Etika exercised on June 30, 2025, requiring purchase of 49%.
• · LGIL is wholly owned by Lotus Advance Technologies Sdn. Bhd., which is 51% owned by Geely HK and 49% owned by Etika.
• · Following the June 10, 2026 share distributions, LGIL ceased to beneficially own more than 5% of the issuer's outstanding shares.
• · No transactions in ordinary shares were effected by the reporting person or covered persons during the past 60 days other than as described.
• · The filing includes an annex listing directors and executive officers of Etika, all Malaysian citizens.